Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

BBNX · ISSUER CIK 1674632

Beta Bionics, Inc.

Between Jul 31, 2026 and Oct 28, 2026, 6 Beta Bionics, Inc. insiders reported $0.00 of open-market purchases and $2.4M of sales on SEC Form 4.

SEC insider filings
↗6 insiders filed

Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 9 of 14 sales were reported under a 10b5-1 plan.

$0.00Insider buying
$2.4MInsider selling
−$2.4MNet open-market
Oct 28, 2026Latest filing
Form 4 trades at Beta Bionics, Inc.
TickerInsiderTypeOwned
Oct 28, 202616:03Oct 26, 2026BBNXChief Commercial OfficerS · Sell10b5-1$20.00−82154,513-1%−$16K
Oct 16, 202616:10Oct 14, 2026BBNXChief Commercial OfficerS · Sell10b5-1$17.35−77555,334-1%−$13K
Oct 5, 202617:11Oct 1, 2026BBNXChief Commercial OfficerS · Sell10b5-1$18.96−37056,109-1%−$7K
Sep 23, 202617:40Sep 22, 2026BBNXDirectorS · Sell10b5-1$23.00−6,43019,564-25%−$148K
Sep 17, 202616:15Sep 16, 2026BBNXChief Commercial OfficerS · Sell10b5-1$20.13−30,77956,479-35%−$620K
Sep 17, 202616:15Sep 16, 2026BBNXChief Product OfficerS · Sell10b5-1$22.00−2,650177,390-1%−$58K
Sep 15, 202616:15Sep 14, 2026BBNXChief Commercial OfficerS · Sell10b5-1$15.52−77586,382-1%−$12K
Sep 10, 202616:30Sep 9, 2026BBNXChief Commercial OfficerS · Sell10b5-1$18.46−36,87087,157-30%−$681K
Sep 4, 202617:19Sep 3, 2026BBNXPresident & CEO, DirectorS · Sell10b5-1$20.08−5,641398,429-1%−$113K
Sep 3, 202618:15Sep 2, 2026BBNXChief Commercial OfficerS · Sell$19.11−5,327124,027-4%−$102K
Sep 3, 202618:15Sep 2, 2026BBNXChief Medical OfficerS · Sell$19.11−4,221169,628-2%−$81K
Sep 3, 202618:15Sep 2, 2026BBNXChief Product OfficerS · Sell$19.11−4,375180,040-2%−$84K
Sep 3, 202618:15Sep 2, 2026BBNXChief Financial OfficerS · Sell$19.11−6,675159,378-4%−$128K
Sep 3, 202618:15Sep 2, 2026BBNXPresident & CEO, DirectorS · Sell$19.11−16,867404,070-4%−$322K
Beta Bionics, Inc. (BBNX) Insider Trading | Shameless Cloning